|
Primary site | Name | Gene symbol | Dysregulation | Sponge target | Function | Clinical value | Possible mechanism | Reference |
|
OSCC | hsa_circ_0000140 | LATS2 | Down | miR-31 | Suppress cell proliferation, migration, and invasion and facilitated cell apoptosis in vitro | A promising prognostic biomarker and potential treatment strategy for OSCC | circ_0000140/miR-31/LATS2 axis | [30] |
| hsa_circ_0005379 | | Down | | Inhibits cancer cell proliferation, invasion | A new therapeutic target for OSCC treatment | Regulate the epidermal growth factor receptor (EGFR) pathway | [31] |
| hsa_circRNA_100533 | GNAS | Down | miR-933 | Inhibit cell proliferation and migration, promote cell apoptosis, and regulate GNAS expression | An effective diagnostic biomarker and therapeutic target for patients with OSCC | hsa_circRNA_100533-miR-933-GNAS axis | [32] |
| circ-PKD2 | APC2 | Down | miR-204-3p | Inhibit OSCC cell proliferation, migration, and invasion, induce apoptosis and cell cycle arrest | A novel pathway involved in the pathogenesis of OSCC and may serve as a novel therapeutic target of OSCC | circ-PKD2/miR-204-3p/APC2 axis | [33] |
| hsa_circRNA_102459 | | Down | | Relate to clinical stage, tumor differentiation, and lymph node metastasis and suppressed TSCC1 cell proliferation, induced cell cycle G0/G1 phase arrest, and promoted apoptosis | A tumor promoter and valuable diagnostic biomarkers of OSCC | | [34] |
| hsa_circRNA_043621 | | Up | | Relate to clinical stage, tumor differentiation, and lymph node metastasis and suppressed TSCC1 cell proliferation, induced cell cycle G0/G1 phase arrest, and promoted apoptosis | A tumor promoter and valuable diagnostic biomarkers of OSCC | | [34] |
| hsa_circ_009755 | | Down | | Associated with T stage of OSCC | A potential biomarker for OSCC diagnosis | | [35] |
| hsa_circ_0072387 | | Down | | Related to TNM stage of OSCC | A potential diagnostic biomarker | | [36] |
| circUHRF1 | UHRF1 | Up | miR-526b-5p | Associated with proliferation, migration, invasion, and epithelial-mesenchymal transformation (EMT) in vitro and the tumor growth in vivo | A potential therapeutic target | circUHRF1/miR-526b-5p/c-Myc/TGF-β1/ESRP1 feedback loop | [37] |
PTC | hsa_circ_0058124 | NUMB | Up | miR-218-5p | Promotes PTC cell proliferation, tumorigenicity, and tumor invasiveness both in vitro and in vivo | A novel biomarker and a novel therapeutic target for intervening in PTC progression | hsa_circ_0058124/NOTCH3/GATAD2A axis | [40] |
| hsa_circ_0006156 | FNDC3B | Up | miR-1178 | Knockdown of circFNDC3B inhibited cell proliferation and promoted cell apoptosis in PTC cells | A promising therapeutic target for the treatment of PTC patients | hsa_circ_0006156/miR-1178/TLR4 pathway | [43] |
| circFOXM1 | FOXM1 | Up | miR-1179 | circFOXM1 downregulation inhibited tumor growth of PTC in vitro and in vivo | A promising therapeutic target for the treatment of PTC patients | circFOXM1/miR-1179/high-mobility group box 1 (HMGB1) axis | [44] |
| circBACH2 | LMO4 | Up | miR-139-5p | Suppress proliferation, migration, and invasion | A promising prognostic biomarker and potential treatment strategy for PTC | circBACH2/miR-139-5p/LMO4 axis | [45] |
| circRAPGEF5 | RAPGEF5 | Up | miR-198 | Beneficial to proliferation, migration, and invasion in vitro | A potential biomarker and therapeutic target for the management of PTC | circRAPGEF5/miR-198/FGFR1 axis | [46] |
LSCC | hsa_circ_0059354 | RASSF2 | Up | miR-302b-3p | Silencing circRASSF2 suppresses progression of LSCC by interacting with miR-302b-3p and decreasing inhibiting IGF-1R expression | A potential biomarker for the diagnosis and prognosis of LSCC | hsa_circ_0059354/miR-302b-3p/IGF-1R axis | [50] |
| hsa_circ_0042666 | TGFBR3 | Down | miR-2238 | Associated with advanced tumor stage, lymph node metastasis, and poor overall survival in LSCC patients | A promising target for LSCC treatment and a tumor suppressor | hsa_circ_0042666/miR-223/TGFBR3 axis | [49] |
| ciRS-7 | CDR1as | Up | miR-7 | Relate with high TNM stages, poorly differentiated tumors, lymph node metastases and poor prognosis of LSCC patients. Enhance cell vitality and promoted the proliferation and migration | An oncogene that promotes LSCC progression | miR-7/CCNE1/PIK3CD signaling pathway | [51] |
NPC | circRNA_000543 | PDGFRB | Up | miR-9 | Associated with poorer overall survival in NPC patients | A potential therapeutic target for radioresistant NPC | miR-9/platelet-derived growth factor receptor B (PDGFRB) axis | [53] |
HSCC | hsa_circ_0058106 | | Up | miR-185-3p | Prevent HSCC cells from undergoing apoptosis | Provide potential candidates for future mechanism studies | | [54] |
| hsa_circ_0036722 | RHCG | Down | miR-671-5p | Facilitate the invasiveness of HSCC | Provide potential candidates for future mechanism studies | | [54] |
MEC | hsa_circ_0012342 | | Down | | Closely related to the pathogenesis of MEC | Potential prognostic biomarkers and therapeutic target of MEC | | [55] |
|